SciELO - Scientific Electronic Library Online

 
vol.59 issue1 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614

Arch. Esp. Urol. vol.59 n.1  Jan./Feb. 2006

 

INTERNATIONAL SECTION

 

Tuberous sclerosis complex. Forty-years of follow-up of a patients affected

Cuarenta años de seguimiento de un paciente con esclerosis tuberosa

 

 

Felip Vallmanya, Jose Placer, Adolf Pou Serradell, Ramon Cortadellas and Antoni Gelabert-Mas

Department of Urology (FV, JP, RC, AG-M), and the Department of Neurology (AP S). Hospital del Mar, IMAS-
Universitat Autònoma de Barcelona. Barcelona. Spain.

Dirección para correspondencia

 

 


SUMMARY

Objectives: To report the case of a patient diagnosed with tuberous sclerosis complex (TSC), describe its clinical features, diagnosis, and to attract attention on the fact that after 40 years of follow-up, the patient has presented practically all the manifestations described in the literature.
Methods: A 42 year-old man diagnosed with TSC presented the emergency department due to left lumbar pain and self-limited gross hematuria. On clinicalexamination patient was haemodynamically stable, but with decrease in haemoglobin (6.8g/ dL). Abdominal CT scan showed a 20 cm diameter heterogeneous mass in the left kidney suggesting hemorrhage of anangiomyolipoma.
Results: Left radical nephrectomy was performed and the pathological study of the surgical specimen confirmed the diagnosis of angiomyolipoma. Inmunohistochemical staining was positive with HMB-45.
Conclusions: To recommend that patients with TSC be evaluated by a multidisciplinary group of clinicians, including urologists, neurologists and dermatologists. As patients with TSC survive into adulthood they will require more intervention by the urologist. CT scan is usually enough for the diagnosis of angiomyolipomas. Complete nephrectomy is appropriate when the whole kidney has been replaced by angiomyolipoma. The identification of molecular markers (HMB-45) facilitates histopathological diagnosis.

Keywords: Tuberous sclerosis complex.Angiomyolipoma. Kidney.


RESUMEN

Objetivos: Presentar un caso singular de un paciente diagnosticado de esclerosis tuberosa, describir sus manifestaciones clínicas, diagnóstico, y llamar la atención sobre el hecho que, tras 40 años de seguimiento el paciente ha presentado prácticamente todas las manifestaciones descritas en la literatura.
Métodos: Hombre de 42 años de edad diagnosticado de esclerosis tuberosa que acude a urgencias por dolor lumbar izquierdo y hematuria macroscópica autolimitada. A la exploración física el paciente se presentaba hemodinámicamente estable, pero con disminución de la hemoglobina (6.8g/ dL). El TAC abdominal mostraba una masa heterogénea de 20 cm. de diámetro en el riñón izquierdo que sugirió hemorragia de angiomiolipoma.
Resultados: Se realizó nefrectomía radical izquierda y el estudio patológico de la pieza quirúrgica confirmó el diagnóstico de angiomiolipoma. El estudio inmunohistoquímico fue positivo para HMB-45.
Conclusiones: Recomendamos que los pacientes con esclerosis tuberosa sean evaluados por un grupo clínico multidisciplinar, que incluyan urólogos, neurólogos y dermatólogos. Como los pacientes con esclerosis tuberosa llegan a la edad adulta requerirán más intervención por los urólogos. El TAC es normalmente suficiente para diagnosticar el angiomiolipoma. La nefrectomía total es apropiada cuando todo el riñón está reemplazado por el angiomiolipoma. La identificación de marcadores moleculares (HMB-45) facilita el diagnóstico histopatológico.

Palabras clave: Esclerosis tuberosa. Angiomiolipoma. Riñón.


 

Introduction

Tuberous sclerosis complex (TSC) is characterized by important neurological involvement, cutaneous manifestations and visceral abnormalities.

The prevalence is estimated to be between 1/5000 and 1/15000 individuals. Tuberous sclerosis is still a clinical diagnosis. Clinical manifestations have been divided into major and minor criteria.

The singularity of the case presented is based on the fact that after 40 years of follow-up (from six months of age), the patient has presented practically all the manifestations described in the literature - having met up to 8 major diagnostic criteria for the disease.

 

Clinical case

Male diagnosed with tuberous sclerosis complex (TSC) after the appearance of seizures at six months of age (1962), hypomelanotic macules and facialangiofibromas after three years of age. Slight mental retardation and periungual fibromas presented during development. (Figure 1)

At sixteen years of age (1978), frontal craniotomy was performed due to obstructive hydrocephalus secondary to a periventricular tumor. A ventricular derivation valve was inserted and the tumor was removed surgically. Histopathological evaluation: giant cell astrocytoma.

Radiographic follow-up studies revealed multiple cortical hamartomas and periventricular bilateral subependymal nodules. (Figure 2)

At 42 years of age (2004), the patient presented to emergency department due to left lumbar pain and self-limited gross hematuria. Haemodynamically stable. Physical exam: palpable mass in the whole lefthemiabdomen. Analytically: Creatinine 1.6 mg/dL, Haemoglobin 6.8 g/dL, leucocytosis of 13500/µL. No alterations in the remaining biochemical parameters.

Abdominal CT Scan: 20 cm diameter mass, liquid, with various densities, in the left upper pole of the kidney and in a subcapsular position, displacing the renal parenchyma ventrally. Multiple low-attenuation nodular elements in both kidneys with some cortical cystic elements and multiple low-attenuation images in the right perirenal fat, suggesting small hemorrhages in the right kidney (Figure 3). The MRI corroborated these findings and revealed an important displacement of the abdominal aorta towards the right side.

Subsequent left radical nephrectomy only identified the kidney’s lower pole, multiple renalangiomyolipomas, multiple lipomas and renal cysts. HMB-45 inmunohistochemical staining was positive.

After six months of follow-up, the patient is asymptomatic and his renal function within normal limits.

 

Discussion

Tuberous sclerosis complex is an organogenesis defect that causes the formation of hamartomas in ectodermal and mesodermal tissues. Autosomal dominant disease originating from a defect on chromosome 9q and 16p (1).

Multisystemic manifestations:

- Dermatological: hypomelanotic macules, angiofibromas in a malar distribution on the face and non-traumatic ungual or periungual fibromas (Koenen tumors). Shagreen patches and café-au-lait macules are other dermatological manifestations (2).

-Neurological: the primary cause of morbidity and mortality (2). Appearance of seizures and mental retardation. There are two types of hamartomas in the central nervous system: cortical tubers which are multiple nodules in the frontal and parietal lobes, and glial subependymal hamartomas, which are also multiple, bilateral, periventricular and can cause obstructive hydrocephalus. This typically happens in the first two decades of life (3). 7-15% of subependymal nodules are a giant cell type astrocytoma.

-Renal: Second leading cause of morbidity and mortality (2). Almost 50% of the patients have angiomyolipomas. Although considered to be hamartomas in the past, angiomyolipomas are now known to be clonal neoplasms (4). Angiomyolipomas in patients with TSC tend to present earlier with larger tumors and greater multiplicity than the sporadic type and require surgical intervention more often (1).

The renal cysts are multiple and bilateral (2).

-Other: lymphangioleiomyomatosis, which also has HMB-45 inmunoreactivity (5). Cardiac rhabdomyoma, retinal glial hamartomas and rectal polyps are other manifestations observed (2).

 

References and recomended reading (*of special interest, **of outstanding interest)

**1. NELSON, C,P.; SANDA, M.G.: “Contemporary diagnosis and management of renal angiomyolipoma”. J. Urol.;168:1315. 2002.        [ Links ]

**2. LENDVAY, T.S.; MARSHALL, F.F.: “The tuberous sclerosis complex and its highly variable manifestations”. J. Urol.;169:1635. 2003.        [ Links ]

*3. CRINO, P.B.; HENSKE, E.P.: “New developments in the neurobiology of the tuberous sclerosis complex”. Neurology; 53:1384. 1999.        [ Links ]

4. CHENG, L.; GU, J.; EBLE, J.N. et al.: “Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas”. Am. J. Surg. Pathol.; 25:1231. 2001.        [ Links ]

5. MAKHLOUF, H.R.; ISHAK, K.G.; SHEKAR, R. et al.: “Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study”. Arch. Pathl. Lab. Med.;126: 49. 2002.        [ Links ]

 

 

Dirección para correspondencia
Felip Vallmanya i Llena, MIR 3.
Servicio de Urología y cátedra
Hospital del Mar.
C/ Passeig Maritim, 25-29
08003 Barcelona. (España)
felip_bb@hotmail.com

Acepted for publication: February 9, 2005

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License